Clik here to view.
Intec Pharma Gets US Patent For Parkinson’s Treatment
Israeli company Intec Pharma has announced that following the successful phase II clinical trial for its accordion capsule, the capsule and procedure will receive a US patent. The accordion capsule is...
View ArticleClik here to view.
Michael J Fox Foundation Grants $750,000 To Intec Pharma
Israeli medical device company Intec Pharma has obtained a $750,000 grant from the J Fox Foundation for Parkinson’s Research. The Israeli company received the grant for its innovative delivery method...
View ArticleClik here to view.
Intec Pharma Raises $5M
Israeli drug development company Intec Pharma has raised $5 million. $2 million will be invested by SPHERA Healthcare, an additional $2 million will be invested by Gabriel Capital Management and the...
View ArticleClik here to view.
Report: Intec To Sign $150M Agreement
April 13, 2015 | Intec Pharma is reportedly set to reach an agreement with a major pharmaceutical company worth $150 million, according to a “Globes” report. According to the terms of the reported...
View ArticleClik here to view.
Intec Pharma To Raise $46M In IPO
June 11, 2015 | The Israeli pharmaceutical company developing a leading Parkinson’s drug, Intec Pharma filed a prospectus with the US SEC to raise up to $46 million in an IPO. Intec Pharma is already...
View ArticleClik here to view.
Intec Pharma Begins Clinical Trials For Ulcer Treatment
December 10, 2015 | Jerusalem based clinical-stage biopharmaceutical company Intec Pharma announced that it is entering a Phase I clinical trial with its third pipeline product. The treatment is based...
View Article
